|
gptkbp:instanceOf
|
gptkb:chemical_compound
dopamine agonist
|
|
gptkbp:administeredBy
|
transdermal patch
|
|
gptkbp:approvalYear
|
2006
|
|
gptkbp:ATCCode
|
gptkb:N04BC09
|
|
gptkbp:brand
|
gptkb:Neupro
|
|
gptkbp:CASNumber
|
gptkb:99755-59-6
|
|
gptkbp:category
|
antiparkinsonian agent
thiophenes
naphthols
|
|
gptkbp:developer
|
gptkb:UCB
Aesica Pharmaceuticals
|
|
gptkbp:hasInChIKey
|
QSLUGMZJZRIWDK-LLVKDONJSA-N
|
|
gptkbp:hasMolecularFormula
|
C19H25NOS
|
|
gptkbp:hasSMILES
|
CN(C)CCC[C@H](O)C1=CC2=C(C=C1)SC=C2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
rotigotine
|
|
gptkbp:KEGGID
|
D08913
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
dopamine receptor agonist
|
|
gptkbp:molecularWeight
|
315.48 g/mol
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1201197
5311272
DB05271
4470702
|
|
gptkbp:routeOfAdministration
|
transdermal
|
|
gptkbp:sideEffect
|
nausea
dizziness
headache
insomnia
somnolence
application site reaction
|
|
gptkbp:synonym
|
(-)-5,6,7,8-tetrahydro-6-[propyl(2-thienylmethyl)amino]-1-naphthol
|
|
gptkbp:UNII
|
KX2P88YEL1
|
|
gptkbp:usedFor
|
gptkb:Parkinson's_disease
gptkb:restless_legs_syndrome
|
|
gptkbp:bfsParent
|
gptkb:Neupro
gptkb:D3R
|
|
gptkbp:bfsLayer
|
8
|